Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10.6 billion as it seeks to accelerate its "rapid expansion" into the oncology market.
Law360 UK
Transactions
WEDNESDAY, JUNE 10, 2026 Law360 iOS App Law360 Android App Follow Law360 on Facebook Follow Law360 on LinkedIn Follow Law360 on Twitter

TOP NEWS

iStock-2177313278.jpg

Davis Polk, Slaughter & May Steer GSK's $10.6B Nuvalent Deal

By Dawood Fakhir

Pharma giant GSK PLC said Tuesday that it has agreed to acquire cancer therapy specialist Nuvalent Inc. for $10.6 billion as it seeks to accelerate its "rapid expansion" into the oncology market.

Read full article » | Save to favorites »

Paramount's $110B Deal For Warner Bros. Faces UK Probe

By Dawood Fakhir

Britain's competition watchdog said Tuesday that it has launched a formal probe into Paramount Skydance's $110 billion deal to buy Warner Bros. Discovery Inc. after it sought initial views on the acquisition in April.

Read full article » | Save to favorites »

JMG Group Buys Insurance Broker Langton London

By Martin Croucher

JMG Group has bought Langton London Insurance Brokers, adding to its specialist commercial insurance business. 

Read full article » | Save to favorites »

LITIGATION

Investment Firm Says Properties Were Undersold By £23.6M

By Sophia Dourou

An investment firm accused a property management company of "presiding over" the "rapid deterioration" of 100 London properties, which were sold for £23.6 million ($31.6 million) less than they were worth, in the first day of a High Court trial Tuesday.

Read full article » | Save to favorites »

CAPITAL MARKETS

Proxy Adviser Backs Nanotech Biz's Plans To Quit LSE

By Irene Madongo

Independent proxy adviser Glass Lewis has recommended that Nanoco Group PLC's shareholders vote in favor of a resolution for the firm to remove its shares from the London Stock Exchange, the nanotech company said on Tuesday.

Read full article » | Save to favorites »

Brief

Data Analysis Biz Eyes Quitting AIM Over 'Considerable' Costs

By Irene Madongo

Data analytics provider SilverBullet said Tuesday that it is seeking shareholder approval to leave London's junior Alternative Investment Market, citing the "considerable" costs and regulatory burden of maintaining its listing.

Read full article » | Save to favorites »

dark blue promo that reads 2026 Titans of the Plaintiffs Bar Promo that reads Law360 Pulse 2026 AI Survey

LAW FIRMS IN TODAY'S NEWS

Cleary Gottlieb

Cravath Swaine

Davis Polk

Debevoise & Plimpton

Latham & Watkins

Ropes & Gray

Sidley Austin

Slaughter and May

Wachtell Lipton

COMPANIES IN TODAY'S NEWS

AstraZeneca PLC

Bank of Scotland PLC

Centerview Partners Holdings LP

Citigroup Inc.

Cleveland Clinic Foundation

Enterprise Chambers

Glass Lewis & Co. LLC

International Brotherhood of Teamsters

Jefferies Financial Group Inc.

Leerink Partners LLC

London Stock Exchange Group PLC

Nasdaq Inc.

Netflix Inc.

Nuvalent Inc.

Skydance Media LLC

Warner Bros. Discovery Inc.

Warner Bros. Entertainment Inc.

GOVERNMENT AGENCIES IN TODAY'S NEWS

Competition and Markets Authority

Food and Drug Administration

New York Attorney General's Office

U.S. Department of Justice

UK High Court